Skip to main content

Cara L. McDermott

Assistant Professor in Medicine
Medicine, Geriatrics and Palliative Care

Overview


Dr. Cara McDermott is an Assistant Professor in Medicine, Division of Geriatrics, at Duke University School of Medicine. She has a K23 award from NIH's National Heart, Lung and Blood Institute on deprescribing fall-risk increasing drugs among multimorbid adults with chronic obstructive pulmonary disease. Her research focuses on identifying gaps in healthcare delivery and using implementation science to adapt and assess evidence-based interventions. Dr. McDermott works to optimize medication use, improve symptom management, and reduce unwanted healthcare use among older adults with multiple chronic conditions, with a particular interest in improving outcomes for patients with cancer, COPD, or dementia and their caregivers.  She is particularly interested in improving shared decision making in this population and medication deprescribing for adults with serious illness. In recent projects, she investigated ways to improve end-of-life care from the perspective of bereaved caregivers and care delivery gaps leading to unwanted healthcare utilization at end of life for patients with multimorbidity. She completed a T32 postdoctoral fellowship with the Cambia Palliative Care Center of Excellence at the University of Washington and a K12 with the University of Washington’s Implementation Sciences Training Program.

Current Appointments & Affiliations


Assistant Professor in Medicine · 2022 - Present Medicine, Geriatrics and Palliative Care, Medicine
Assistant Professor in Population Health Sciences · 2022 - Present Population Health Sciences, Basic Science Departments
Member of the Duke Cancer Institute · 2025 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Characterizing Intervention Components and Complexity of Nonpharmacologic Healthcare Interventions to Manage Distress Behaviors in Older Adults.

Journal Article J Appl Gerontol · April 28, 2025 Distress behaviors are common in residential care settings and contribute to staff burnout and poor quality of life for older adults. While nonpharmacologic interventions reduce distress behaviors, implementation in routine care remains challenging. Our st ... Full text Link to item Cite

Opioids and benzodiazepines in oncology: Perspectives on coprescribing and mitigating risks.

Journal Article J Geriatr Oncol · March 2025 INTRODUCTION: Opioids and benzodiazepines are commonly prescribed for cancer symptoms. In combination, they can increase the risk of adverse events, particularly for older adults with multimorbidity, who represent most patients with cancer. We aimed to und ... Full text Link to item Cite

LIVING WITH MULTIMORBIDITY AND FINANCIAL TOXICITY: A PATIENT- AND CLINICIAN-INFORMED FRAMEWORK

Conference Innovation in Aging · December 31, 2024 AbstractMost older adults in the US have multimorbidity (2+ serious illnesses). Living with multimorbidity impacts patient quality of life, specifically managing the symptoms of multiple diseases and accompa ... Full text Cite
View All Publications

Recent Grants


Models of Post-Acute Care in Complex Older Adults with Fracture

ResearchCo Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2024 - 2030

Duke/UNC ADAR Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Reducing Polypharmacy and Fall Risk for Multi-Morbid Adults with Chronic Obstructive Pulmonary Disease

ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026

View All Grants

Education, Training & Certifications


University of Washington · 2016 Ph.D.